论文部分内容阅读
醋酸去炎松鉴定会于1973年5月7～8日由天津市制药工业公司主持在天津召开。参加会议的有来自北京、上海、辽宁、吉林、湖南、内蒙古、天津等省市和部队的医疗卫生、科研、商业、生产和有关领导部门共31个单位,63名代表。会上,天津市天津制药厂、为民制药厂、人民制药厂对醋酸去炎松及其制剂的试制和试生产工艺、质量、技术经济指标等作了介绍;北京首都医院、空军总医院、天津医学院附属医院、第一中心医院等13个医疗单位介绍了该药的临床治疗情况。代表们用一分为二的观点,进行了认真的讨论和交流,一致认为: 1.醋酸去炎松是一皮质激素类药物,其抗炎作用比氢化可的松大20～40倍,可减轻机体
Identification of triamcinolone acetate will be held in Tianjin on July 7 to May 8, 1973, held by Tianjin Pharmaceutical Industry Corporation in Tianjin. Attending the meeting were 31 units and 63 representatives from medical, scientific, commercial, production and related leading departments from Beijing, Shanghai, Liaoning, Jilin, Hunan, Inner Mongolia and Tianjin, and other units. At the meeting, Tianjin Tianjin Pharmaceutical Factory, People’s Pharmaceutical Factory and People’s Pharmaceutical Factory introduced the trial manufacture and trial production technology, quality, technical and economic indexes of Triamcinolone Acetonide and its preparations; Beijing Capital Hospital, Air Force General Hospital, Tianjin Medical College Hospital, the First Central Hospital and other 13 medical units introduced the clinical treatment of the drug. The delegates took a dichotomous view and conducted serious discussions and exchanges. They all agreed that: 1. Triamcinolone acetate is a corticosteroid drug whose anti-inflammatory effect is 20 to 40 times greater than that of hydrocortisone, Reduce the body